Spironolactone Tablet
Product Images NDC 72162-2683

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 72162-2683). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622683)

Label (Lbl721622683)
Label for Spironolactone Tablets, USP 50 mg oral tablets, NDC 72162-2683-1. The label states the product contains 50 mg spironolactone per tablet and comes in a 100-tablet quantity. It includes storage instructions to keep in light-resistant containers at 20° to 25°C and to keep out of reach of children. The label shows Bryant Ranch Prepack as the repackager and Aurobindo Pharma Limited as the manufacturer, with QR codes present for prescribing information and package insert.*
FDA Label Image

Figure (Spironolactone Fig1)

Figure (Spironolactone Fig1)
A Kaplan-Meier survival curve chart comparing Spironolactone (822 participants) versus Placebo (841 participants) over 48 months. The y-axis shows probability ranging from 0 to 1; the x-axis shows time in months. Spironolactone shows higher survival probability than placebo, with a log-rank p-value less than 0.001 indicating statistical significance.*
FDA Label Image

Fig2 (Spironolactone Fig2)

Fig2 (Spironolactone Fig2)
A forest plot displaying hazard ratios (HR) and 95% confidence intervals (CIs) for various subgroups, including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACEI use, and beta blocker use. The horizontal axis ranges from 0.2 to 1.4, indicating comparative effectiveness where values less than 1 favor spironolactone over placebo in a human prescription drug context.*
FDA Label Image

Str1 (Spironolactone Str1)

Str1 (Spironolactone Str1)
Chemical structure diagram of spironolactone, showing its steroid backbone and functional groups, consistent with the active ingredient in spironolactone tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.